ArticleJournal of medical case reports2026
Acute rheumatic fever or rheumatoid arthritis? The role of hydroxychloroquine: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatic fever is endemic in our part of the world. Arthritis is the most common clinical presentation and is characteristically migratory in nature. Rheumatoid-like arthritis in acute rheumatic fever is not described in literature. Although arthritis is typically treated with nonsteroidal anti-inflammatory drugs, the role of hydroxychloroquine remains less well studied. CASE PRESENTATION: A 24-year-old Pakistani female individual presented with symmetrical polyarthritis involving the small joints of the hands along with morning stiffness. She was diagnosed with rheumatic heart disease in 2011, when she initially presented with arthritis and mild mitral regurgitation. On current evaluation, her echocardiography showed worsening heart disease, with severe mitral regurgitation, moderate aortic regurgitation, moderate tricuspid regurgitation, severe pulmonary hypertension, and good biventricular systolic function. Her antistreptolysin O titer and C-reactive protein levels were raised. She was started on nonsteroidal anti-inflammatory drugs but showed no response.The patient was referred to a rheumatologist and managed with immunosuppressive drugs, including hydroxychloroquine. Her arthritis settled, the aortic regurgitation regressed, and she was discharged in stable condition following mitral valve replacement. Features favoring rheumatic arthritis in this case included the presence of rheumatic heart disease, elevated antistreptolysin O titer, and response to benzathine penicillin. Features suggestive of rheumatoid arthritis included poor response to nonsteroidal anti-inflammatory drugs and the pattern of joint involvement (symmetrical polyarthritis of the small joints of the hands with morning stiffness). Group A streptococcal infection can trigger interleukin-1 beta-mediated granulocyte-monocyte colony-stimulating factor and interferon gamma + CD4 T cell expansion, mechanisms implicated in autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus. Similarly, granulocyte-monocyte colony-stimulating factor plays an important role in the pathogenesis of rheumatic heart disease following acute rheumatic fever. Hydroxychloroquine suppresses granulocyte-monocyte colony-stimulating factor and may therefore be effective in these patients.
conclusionImmunosuppressive drugs may be beneficial in treating these patients, as they behave exactly the same way as patients of other autoimmune disorders. Streptococcus acts as a trigger for the activation of the immune system. The clinical picture can vary depending upon the immune response activated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.